The European project BT4ChildLC, led by the Germans Trias i Pujol Research Institute (IGTP), has laid the foundations for more precise diagnosis and treatment strategies for childhood liver cancer by ...
Read more
Los hallazgos refuerzan la relación entre el entorno, la obesidad y la salud metabólica desde edades tempranas y suponen un avance hacia estrategias de medicina de precisión orientadas a detectar p...
Read more
The study, led by the Institute for Neurosciences CSIC-UMH and EPFL (Switzerland), shows that the molecule OLE helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicit...
Read more
Aplicar la misma estrategia en pacientes implica buscar fármacos que bloqueen la vía molecular de KRAS en los mismos tres puntos. El equipo empleó una terapia triple, que combinaba un inhibidor de ...
Read more
Este hallazgo abre la puerta a tratamientos más personalizados para pacientes con tumores poco frecuentes que actualmente cuentan con pocas opciones terapéuticas.
Read more
The work, led by IRB Barcelona, shows that tumours with chromosomal instability can promote their own growth by damaging the surrounding healthy tissues.
Read more
Many repetitive regions of the genome have been considered “junk DNA” because the technologies available did not allow them to be studied at sufficient resolution. This is the case with the SST1/N...
Read more
Elaboran un documento de consenso internacional que analiza los avances y los retos de la secuenciación genómica para predecir la sensibilidad de las bacterias a los antibióticos, una tecnología l...
Read more
La nueva herramienta, basada en tecnología CRISPR, permite identificar en pocas horas la bacteria Pseudomonas aeruginosa y uno de sus factores de virulencia más agresivos.
Read more
The researcher will study how the tumour environment influences the response to Pan-KRAS inhibitors, one of the most promising therapeutic strategies against pancreatic ductal adenocarcinoma.
Read more
The project aims to determine how genetic alterations affecting the BAF complex, and the epigenetic changes they trigger, contribute to treatment resistance and disease progression.
Read more
Barcelona hosts the Kick-Off meeting of the new European research project from IDIBAPS HypoGluTx, focused on preclinical therapy studies for rare diseases using small molecules and biologicals.
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
